The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Open accessAbstract
The emergence of antibiotic resistant bacteria in the healthcare is a serious concern. In the Healthcare premises precisely intensive care unit are major sources of microbial diversity. Recent findings have demonstrated not only microbial diversity but also drug resistant microbes largely habitat in ICU. Pseudomonas aeruginosa found as a part of normal intestinal flora and a significant pathogen responsible for wide range of ICU acquired infection in critically ill patients. Nosocomial infection associated with this organism including gastrointestinal infection, urinary tract infections and blood stream infection. Infection caused by this organism are difficult to treat because of the presence of its innate resistance to many antibiotics (β-lactam and penem group of antibiotics), and its ability to acquire further resistance mechanism to multiple class of antibiotics, including Beta-lactams, aminoglycosides and fluoroquinolones. In the molecular evolution microbes adopted several mechanism to maintain genomic plasticity. The tool microbe use for its survival is mainly biofilm formation, quorum sensing, and horizontal gene transfer and enzyme promiscuity. Such genomic plasticity provide an ideal habitat to grow and survive in hearse environment mainly antibiotics pressure. This review focus on infection caused by Pseudomonas aeruginosa , its mechanisms of resistance and available treatment options. The present study provides a systemic review on major source of Pseudomonas aeruginosa in ICU. Further, study also emphasizes virulence gene/s associated with Pseudomonas aeruginosa genome for extended drug resistance. Study gives detailed overview of antibiotic drug resistance mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, P. aeruginosa belongs to Gram-negative bacteria similar to E. coli and is characterized by a 100 times lower permeability outer membrane than E. coli [68], while NC/PE sponges showed partial growth inhibition against P. aeruginosa and no inhibition against E. coli.”
From Plant-Derived Nanocellulose with Antibacterial Activity for Wound Healing Dressing (2023) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Commensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Biofilms and Device-Associated Infections
Donlan, R. M. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010226 · Cited by 1,504
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Pseudomonas aeruginosa – a phenomenon of bacterial resistance
Strateva, T., & Yordanov, D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009142-0 · Cited by 803
Engineering out the Risk of Infection with Urinary Catheters
Maki, D. G., & Tambyah, P. A. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010240 · Cited by 750
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.
Lambert, P. A. (2002) · Europe PMC (PubMed Central) · Cited by 677
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
Köck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S., Kluytmans, J., Mielke, M., Peters, G., Skov, R. L., Struelens, M. J., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.41.19688-en · Cited by 611
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 470
Paul, M., Benuri-Silbiger, I., Soares-Weiser, K., & Leibovici, L. (2004) · BMJ · doi:10.1136/bmj.38028.520995.63 · Cited by 466
Colistin, mechanisms and prevalence of resistance
Bialvaei, A. Z., & Kafil, H. S. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1018989 · Cited by 460
Meyer, J.-M. (2000) · Archives of Microbiology · doi:10.1007/s002030000188 · Cited by 437
Lledo, W., Hernández, M., Lopez, E., Molinari, O. L., Soto, R. Q., Hernández, E., Vispo, N. S., Flores, M., Vázquez, G. J., Robledo, I. E., et al. (2009) · PubMed · Cited by 430
Arancibia, F., Bauer, T. T., Ewig, S., Mensa, J., Gonzalez, J., Niederman, M. S., & Torres, A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1849 · Cited by 401
Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa
Brewer, S. C., Wunderink, R. G., Jones, C. B., & Leeper, K. V. (1996) · Chest · doi:10.1378/chest.109.4.1019 · Cited by 361
The rising problem of antimicrobial resistance in the intensive care unit
Brusselaers, N., Vogelaers, D., & Blot, S. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-47 · Cited by 350
Nathwani, D., Raman, G., Sulham, K., Gavaghan, M., & Menon, V. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-32 · Cited by 344
Obritsch, M. D., Fish, D. N., MacLaren, R., & Jung, R. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.10.1353 · Cited by 342
Historical evolution and current status of the taxonomy of genus Pseudomonas
Peix, A., Ramírez-Bahena, M.-H., & Velázquez, E. (2009) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2009.08.001 · Cited by 323
Urinary tract infections caused by Pseudomonas aeruginosa: A minireview
Mittal, R., Aggarwal, S., Sharma, S., Chhibber, S., & Harjai, K. (2009) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2009.08.003 · Cited by 312
Pseudomonas aeruginosa : Growth in Distilled Water from Hospitals
Favero, M. S., Carson, L. A., Bond, W. W., & Petersen, N. J. (1971) · Science · doi:10.1126/science.173.3999.836 · Cited by 291
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286
Trautmann, M., Lepper, P. M., & Haller, M. (2005) · American Journal of Infection Control · doi:10.1016/j.ajic.2005.03.006 · Cited by 282
Angus, B. L., Carey, A. M., Caron, D. A., Kropinski, A. M., & Hancock, R. E. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.2.299 · Cited by 262
Ventilator associated pneumonia
Hunter, J. D. (2012) · BMJ · doi:10.1136/bmj.e3325 · Cited by 254
Chatzinikolaou, I., Abi-Said, D., Bodey, G. P., Rolston, K. V. I., Tarrand, J. J., & Samonis, G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.501 · Cited by 238
Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K., Shaw, K. J., & Groups, A. R. S. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s46 · Cited by 235
The development of bacterial biofilms on indwelling urethral catheters
Morris, N. S., Stickler, D. J., & McLean, R. J. C. (1999) · World Journal of Urology · doi:10.1007/s003450050159 · Cited by 210
Kollef, M. H., Chastre, J., Fagon, J.-Y., François, B., Niederman, M. S., Rello, J., Torres, A., Vincent, J.-L., Wunderink, R. G., Go, K. W., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000510 · Cited by 203
Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome
Nseir, S., Di Pompeo, C., Pronnier, P., Beague, S., Onimus, T., Saulnier, F., Grandbastien, B., Mathieu, D., Delvallez-Roussel, M., & Durocher, A. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00012902 · Cited by 203
Bouza, E., Juan, R. S., Muñoz, P., Voss, A., & Kluytmans, J. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1198-743x.2001.00326.x · Cited by 201
Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms
Bagge, N., Hentzer, M., Andersen, J. B., Ciofu, O., Givskov, M., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1168-1174.2004 · Cited by 192
Bert, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf069 · Cited by 180
Juan, C., Maciá, M. D., Gutiérrez, O., Vidal, C., Pérez, J. L., & Oliver, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4733-4738.2005 · Cited by 175
Infection in Hospitalized Trauma Patients: Incidence, Risk Factors, and Complications
Papia, G., McLellan, B. A., El-Helou, P., Louie, M., Rachlis, A., Szalai, J.-P., & Simor, A. E. (1999) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199911000-00018 · Cited by 173
Identification and characterization of novel pyoverdine synthesis genes in Pseudomonas aeruginosa
Lamont, I. L., & Martin, L. W. (2003) · Microbiology · doi:10.1099/mic.0.26085-0 · Cited by 169
Thaden, J. T., Park, L. P., Maskarinec, S. A., Ruffin, F., Fowler, V. G., & van Duin, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02671-16 · Cited by 168
Llano-Sotelo, B., Azucena, E. F., Kotra, L. P., Mobashery, S., & Chow, C. S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00125-4 · Cited by 167
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients
Tumbarello, M., De Pascale, G., Trecarichi, E. M., Spanu, T., Antonicelli, F., Maviglia, R., Pennisi, M. A., Bello, G., & Antonelli, M. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2828-9 · Cited by 167
Chemaly, R. F., Simmons, S., Dale, C., Ghantoji, S. S., Rodriguez, M., Gubb, J., Stachowiak, J., & Stibich, M. (2014) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936114543287 · Cited by 166
Bacterial Pneumonia in Hospitalized Patients With HIV Infection
Afessa, B., & Green, B. (2000) · Chest · doi:10.1378/chest.117.4.1017 · Cited by 160
Pseudomonas aeruginosa : infections and treatment
Baltch, A. L., & Smith, R. P. (1994) · Marcel Dekker eBooks · Cited by 159
Kallel, H., Hergafi, L., Bahloul, M., Hakim, A., Dammak, H., Chelly, H., Hamida, C. B., Chaari, A., Rekik, N., & Bouaziz, M. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0675-2 · Cited by 154
Risk factors for infection byPseudomonas aeruginosa in patients with ventilator-associated pneumonia
Rello, J., Ausina, V., Ricart, M., Puzo, C., Quintana, E., Net, A., & Prats, G. (1994) · Intensive Care Medicine · doi:10.1007/bf01704699 · Cited by 151
Martín‐Loeches, I., Deja, M., Koulenti, D., Dimοpoulos, G., Marsh, B. J., Torres, A., Niederman, M. S., Rello, J., & EU-VAP Study Investigators (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2808-5 · Cited by 147
Jarvis, W. R., Schlosser, J., Chinn, R., Tweeten, S., & Jackson, M. M. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.009 · Cited by 144
Okamoto, K., Gotoh, N., & Nishino, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.1964-1971.2001 · Cited by 137
Horcajada, J. P., Shaw, E., Padilla, B., Pintado, V., Calbo, E., Benito, N., Gamallo, R., Gozalo, M., & Rodríguez‐Baño, J. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12089 · Cited by 133
de Abreu, P. M., Farias, P., Paiva, G. E., de Almeida, A. M. S. F., & Morais, P. V. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-118 · Cited by 120
Saiman, L. M., Chen, Y., Gabriel, P. S., & Knirsch, C. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1105-1107.2002 · Cited by 108
Furtado, G. H. C., d’Azevedo, P. A., Santos, A. F., Gales, A. C., Pignatari, A. C. C., & Medeiros, E. A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.017 · Cited by 104
MacLeod, D. L., Nelson, L. E., Shawar, R. M., Lin, B. B., Lockwood, L. G., Dirk, J. E., Miller, G. H., Burns, J. L., & Garber, R. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315312 · Cited by 95
Mortality Attributable to Nosocomial Infections in the ICU
Fagon, J.-Y., Novara, A., Stéphan, F., Girou, E., & Safar, M. E. (1994) · Infection Control and Hospital Epidemiology · doi:10.2307/30148490 · Cited by 94
Kritsotakis, E. I., Kontopidou, F. V., Astrinaki, E., Roumbelaki, M., Ioannidou, E., & Gikas, A. I. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s147459 · Cited by 94
Park, S.-Y., Park, H. J., Moon, S. M., Park, K., Chong, Y. P., Kim, M., Kim, S., Lee, S., Kim, Y. S., Woo, J. H., et al. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-308 · Cited by 92
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Lü, Q., Eggimann, P., Luyt, C. E., Wolff, M., Tamm, M., François, B., Mercier, E., Garbino, J., Laterre, P., Koch, H., et al. (2014) · Critical Care · doi:10.1186/cc13697 · Cited by 91
Esposito, S., & Leone, S. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.10.017 · Cited by 79
Pulicherla, K. K., & Verma, M. K. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0287-z · Cited by 66
Montero, M., Sala, M., Riu, M., Belvis, F. X., Salvadó, M., Grau, S., Horcajada, J. P., Álvarez-Lerma, F., Terradas, R., Orozco‐Levi, M., et al. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0850-1 · Cited by 66
Intensive care unit acquired infection: a prevalence and impact on morbidity and mortality
Vosylius, S., Šipylaitė, J., & Ivaškevičius, J. (2003) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2003.00230.x · Cited by 58
Clinical Approach to the Patient With Suspected Ventilator-Associated Pneumonia
Vidaur, L., Sirgo, G., Rodríguez, A. H., & Rello, J. (2005) · Respiratory Care · doi:10.4187/respcare.05500965 · Cited by 48
Djordjevic, Z. M., Folić, M., Zivic, Z. P., Marković, V., & Јаnkovic, S. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.02.018 · Cited by 46
Moore, L. S. P., Freeman, R., Gilchrist, M. J., Gharbi, M., Brannigan, E., Donaldson, H., Livermore, D. M., & Holmes, A. H. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku307 · Cited by 45
Leroy, O., d’Escrivan, T., Devos, P., Dubreuil, L. J., Kipnis, É., & Georges, H. (2005) · Infection · doi:10.1007/s15010-005-4021-8 · Cited by 41
Di, X., Wang, R., Liu, B., Zhang, X., Ni, W., Wang, J., Liang, B., Cai, Y., & Liu, Y.-N. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.27 · Cited by 39
Enzyme promiscuity in earthworm serine protease: substrate versatility and therapeutic potential
Verma, M. K., & Pulicherla, K. K. (2016) · Amino Acids · doi:10.1007/s00726-015-2162-3 · Cited by 38
EVIDENCE FOR DYNAMIC PHENOMENA IN RESIDUAL TRACHEAL TUBE BIOFILM
Inglis, T. J. J. (1993) · British Journal of Anaesthesia · doi:10.1093/bja/70.1.22 · Cited by 37
Year in review 2011: Critical Care - infection
Afshari, A., Pagani, L., & Harbarth, S. (2012) · Critical Care · doi:10.1186/cc11421 · Cited by 37
Verma, M. K., & Pulicherla, K. K. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.090 · Cited by 35
Year in review 2010: Critical Care - infection
Pagani, L., Afshari, A., & Harbarth, S. (2011) · Critical Care · doi:10.1186/cc10425 · Cited by 34
Surgical Site Infections and Antimicrobial Resistance Pattern
Chaudhary, R., Thapa, S. K., Rana, J. C., & Shah, P. K. (2017) · Journal of Nepal Health Research Council · doi:10.3126/jnhrc.v15i2.18185 · Cited by 30
Pérez-Sánchez, L., González, E., Colón-Lorenzo, E. E., González-Velázquez, W., Gonzalez-Mendez, R. R., & Valle, N. R.-D. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-317 · Cited by 23
Patwardhan, V. V., & Singh, S. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1627-6 · Cited by 22
Liew, Y. X., Tan, T.-T., Lee, W., Ng, J.-L., Chia, D.-Q., Wong, G.-C., & Kwa, A. L. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.02.025 · Cited by 19
COLISTIN, AN OPTION FOR TREATMENT OF MULTIPLE DRUG RESISTANT PSEUDOMONAS AERUGINOSA
Memar, M. Y., Pormehrali, R., Alizadeh, N., & Ghotaslou, R. (2016) · Cited by 14
Hospital-acquired infections caused by antibiotic resistant bacteria
Krzowska-Firych, J., Kozłowska, A., Sukhadia, T., & Al-Mosawi, L. K. (2014) · Postępy Nauk Medycznych · Cited by 5
Elsayed, A., & Abdulrahman, A. A. (2014) · African Journal of Microbiology Research · doi:10.5897/ajmr2013.6477 · Cited by 5
Cited by
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Denissen, J., Reyneke, B., Waso-Reyneke, M., Havenga, B., Barnard, T., Khan, S., & Khan, W. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114006 · Cited by 395
Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review
Parmanik, A., Das, S., Kar, B., Bose, A., Dwivedi, G. R., & Pandey, M. M. (2022) · Current Microbiology · doi:10.1007/s00284-022-03061-7 · Cited by 277
Metadata
- Authors
- Pachori, P., Gothalwal, R., & Gandhi, P.
- Venue
- Genes & Diseases
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 6
- Issue
- 2
- Pages
- 109-119
- ISSN
- 2352-3042 (ISSN-L)
- OpenAlex
- W2939347585
- Cited by
- 620
- References
- 88
- FWCI
- 19.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.